10. Atopic dermatitis

Journal of Allergy and Clinical Immunology

Volumn 117, Issue 2 SUPPL. 2, 2006, Pages

  Boguniewicz, Mark ^a   Leung, Donald Y M ^b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b NONE

Author keywords

Antimicrobial peptides; Atopic dermatitis; Chemokines; Cytokines; Dendritic cells; Superantigens; Topical calcineurin inhibitors

Indexed keywords

CALCINEURIN INHIBITOR; CHEMOKINE; CYTOKINE; FLUTICASONE PROPIONATE; PEPTIDE; PIMECROLIMUS; STEROID;

ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ASTHMA; ATOPIC DERMATITIS; CLINICAL TRIAL; FOOD ALLERGY; HUMAN; IMMUNE RESPONSE; PRIORITY JOURNAL; REVIEW;

EID: 31544453898     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.10.018     Document Type: Article

References (43)

1. A. Blauvelt, S.T. Hwang, and M.C. Udey Allergic and immunologic diseases of the skin J Allergy Clin Immunol 111 suppl 2003 S560 S570
2. D.Y.M. Leung, M. Boguniewicz, M. Howell, I. Nomura, and Q. Hamid New insights into atopic dermatitis J Clin Invest 113 2004 651 657
3. S.H. Sicherer, and D.Y. Leung Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insect stings J Allergy Clin Immunol 114 2004 118 124
4. A. Semper, K. Heron, A. Woollard, J. Kochan, P. Friedmann, and M. Church Surface expression of FcεRI on Langerhans' cells of clinically uninvolved skin is associated with disease activity in atopic dermatitis, allergic asthma, and rhinitis J Allergy Clin Immunol 112 2003 411 419
5. J.M. Spergel, and A.S. Paller Atopic dermatitis and the atopic march J Allergy Clin Immunol 112 suppl 2003 S118 S127
6. M.A. Ben-Gashir, P.T. Seed, and R.J. Hay Predictors of atopic dermatitis severity over time J Am Acad Dermatol 50 2004 349 356
7. N. Novak, T. Bieber, and D.Y.M. Leung Immune mechanisms leading to atopic dermatitis J Allergy Clin Immunol 112 suppl 2003 S128 S139
8. N. Novak, J.P. Allam, and T. Bieber Allergic hyperreactivity to microbial components: a trigger factor of "intrinsic" atopic dermatitis? J Allergy Clin Immunol 112 2003 215 216
9. D. Laouini, H. Alenius, P.O. Bryce, H. Oettgen, E. Tsitsikov, and R.S. Geha IL-10 is critical for Th2 responses in a murine model of allergic dermatitis J Clin Invest 112 2003 1058 1066
10. M.D. Howell, N. Novak, T. Bieber, S. Pastore, G. Girolomoni, and M. Boguniewicz Interleukin-10 down-regulates anti-microbial peptide expression in atopic dermatitis J Invest Dermatol 125 2005 738 745
11. K. Kerschenlohr, S. Decard, U. Darsow, M. Ollert, and A. Wollenberg Clinical and immunologic reactivity to aeroallergens in "intrinsic" atopic dermatitis patients J Allergy Clin Immunol 111 2003 195 197
12. S.G.O. Johansson, T. Bieber, R. Dahl, P.S. Friedmann, B.Q. Lanier, and R.L. Lockey Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003 J Allergy Clin Immunol 113 2004 832 836
13. N. Novak, S. Kraft, and T. Bieber Unraveling the mission of FcεRI on antigen-presenting cells J Allergy Clin Immunol 111 2003 38 44
14. N. Novak, B. Bohle, S. Laffer, J. Haberstok, S. Kraft, and T. Bieber FcεRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro J Allergy Clin Immunol 113 2004 949 957
15. K. Kerschenlohr, S. Decard, B. Przybilla, and A. Wollenberg Atopy patch test reactions show a rapid influx of inflammatory dendritic epidermal cells in patients with extrinsic atopic dermatitis and patients with intrinsic atopic dermatitis J Allergy Clin Immunol 111 2003 869 874
16. M. Akdis, A. Trautmann, S. Klunker, I. Daigle, U.C. Kucuksezer, and W. Deglmann T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells FASEB J 17 2003 1026 1035
17. M. Toda, D.Y. Leung, S. Molet, M. Boguniewicz, R. Taha, and P. Christodoulopoulos Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions J Allergy Clin Immunol 111 2003 875 881
18. S.J. Ono, T. Nakamura, D. Miyazaki, M. Ohbayashi, M. Dawson, and M. Toda Chemokines: roles in leukocyte development, trafficking, and effector function J Allergy Clin Immunol 111 2003 1185 1199
19. I. Nomura, B. Gao, M. Boguniewicz, M.D. Darst, J.B. Travers, and D.Y.M. Leung Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis J Allergy Clin Immunol 112 2003 1195 1202
20. S.R. Dillon, C. Sprecher, A. Hammond, J. Bilsborough, M. Rosenfeld-Franklin, and S.R. Presnell Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice Nat Immunol 5 2004 752 760
21. C. Gunther, C. Bello-Fernandez, T. Kopp, J. Kund, N. Carballido-Perrig, and S. Hinteregger CCL18 is expressed in atopic dermatitis and mediates skin homing of human memory T cells J Immunol 174 2005 1723 1728
22. A. Pivarcsi, M. Gombert, M.C. Dieu-Nosjean, A. Lauerma, R. Kubitza, and S. Meller CC chemokine ligand 18, an atopic dermatitis-associated and dendritic cell-derived chemokine, is regulated by staphylococcal products and allergen exposure J Immunol 173 2004 5810 5817
23. M. Gombert, M.C. Dieu-Nosjean, F. Winterberg, E. Bunemann, R.C. Kubitza, and L. Da Cunha CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation J Immunol 174 2005 5082 5091
24. D.J. Hijnen, M. de Bruin-Weller, B. Oosting, C. Lebre, E. de Jong, and C. Bruijnzeel-Koomen Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis J Allergy Clin Immunol 113 2004 334 340
25. L.-S. Ou, E. Goleva, C. Hall, and D.Y. Leung T regulatory cells in atopic dermatitis and subversion of their activity by superantigens J Allergy Clin Immunol 113 2004 756 763
26. P.Y. Ong, T. Ohtake, C. Brandt, I. Strickland, M. Boguniewicz, and T. Ganz Endogenous antimicrobial peptides and skin infections in atopic dermatitis N Engl J Med 347 2002 1151 1160
27. I. Nomura, E. Goleva, M.D. Howell, Q.A. Hamid, P.Y. Ong, and C.F. Hall Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes J Immunol 171 2003 3262 3269
28. M.D. Howell, J.F. Jones, K.O. Kisich, J.E. Streib, R.L. Gallo, and D.Y. Leung Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum J Immunol 172 2004 1763 1767
29. B. Deslouches, S.M. Phadke, V. Lazarevic, M. Cascio, K. Islam, and R.C. Montelaro De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity Antimicrob Agents Chemother 49 2005 316 322
30. U. Darsow, J. Laifaoui, K. Kerschenlohr, A. Wollenberg, B. Przybilla, and B. Wuthrich The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study Allergy 59 2004 1318 1325
31. K. Breuer, A. Heratizadeh, A. Wulf, U. Baumann, A. Constien, and D. Tetau Late eczematous reactions to food in children with atopic dermatitis Clin Exp Allergy 34 2004 817 824
32. J. Berth-Jones, R.J. Damstra, S. Golsch, J.K. Livden, O. Van Hooteghem, and F. Allegra Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study BMJ 326 2003 1367 1372
33. S.F. Friedlander, A.A. Hebert, and D.B. Allen for the Fluticasone Pediatrics Safety Study Group. Safety of fluticasone propionate cream 0.05% for the treatment of severe and extensive atopic dermatitis in children as young as 3 months J Am Acad Dermatol 46 2002 387 393
34. M. Boguniewicz, L.F. Eichenfield, and T. Hultsch Current management of atopic dermatitis and interruption of the atopic march J Allergy Clin Immunol 112 suppl 2003 S140 S150
35. V.C. Ho, A. Gupta, R. Kaufmann, G. Todd, F. Vanaclocha, and R. Takaoka Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants J Pediatr 142 2003 155 162
36. A. Kapp, K. Papp, A. Bingham, R. Folster-Holst, J.P. Ortonne, and P.C. Potter Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug J Allergy Clin Immunol 110 2002 277 284
37. R. Kaufmann, R. Folster-Holst, P. Hoger, D. Thaci, H. Loffler, and D. Staab Onset of action of pimecrolimus cream 1% in the treatment of atopic eczema in infants J Allergy Clin Immunol 114 2004 1183 1188
38. M.S. Chapman, L.A. Schachner, D. Breneman, M. Boguniewicz, M.H. Gold, and T. Shull Tacrolimus ointment 0.03% shows efficacy and safety in pediatric and adult patients with mild to moderate atopic dermatitis J Am Acad Dermatol 53 suppl 2005 S177 S185
39. L.A. Schachner, C. Lamerson, M.P. Sheehan, M. Boguniewicz, J. Mosser, and S. Raimer Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study Pediatrics 116 2005 e334 e342
40. J.M. Hanifin, A.S. Paller, L. Eichenfield, R.A. Clark, N. Korman, and G. Weinstein Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis J Am Acad Dermatol 53 suppl 2005 S186 S194
41. U. Wahn, J.D. Bos, M. Goodfield, R. Caputo, K. Papp, and A. Manjra Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children Pediatrics 110 2002 e2
42. D.Y.M. Leung, R.A. Nicklas, J.T. Li, I.L. Bernstein, J. Blessing-Moore, and M. Boguniewicz Disease management of atopic dermatitis: an updated practice parameter Ann Allergy Clin Immunol 93 suppl 2004 S1 S21
43. L. Fonacier, J. Spergel, E.N. Charlesworth, D. Weldon, V. Beltrani, and J. Bernhisel-Broadbent Report of the Topical Calcineurin Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology J Allergy Clin Immunol 115 2005 1249 1253